FORTRESS BIOTECH INC (FBIO) Forecast, Price Target & Analyst Ratings

NASDAQ:FBIO • US34960Q3074

Current stock price

2.35 USD
-0.05 (-2.08%)
At close:
2.3781 USD
+0.03 (+1.2%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FORTRESS BIOTECH INC (FBIO).

Forecast Snapshot

Consensus Price Target

Price Target
$10.97
+ 366.60% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.97
Upside
+ 366.60%
From current price of $2.35 to mean target of $10.97, Based on 8 analyst forecasts
Low
$4.55
Median
$10.97
High
$17.85

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for FBIO. The average price target is 10.97 USD. This implies a price increase of 366.6% is expected in the next year compared to the current price of 2.35.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FBIO Current Analyst RatingFBIO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

FBIO Historical Analyst RatingsFBIO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
FBIO was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about FBIO.
In the previous month the buy percentage consensus was at a similar level.
FBIO was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-23HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-21HC Wainwright & Co.Maintains Buy -> Buy
2025-03-11Roth MKMReiterate Buy -> Buy
2024-11-18HC Wainwright & Co.Maintains Buy -> Buy
2024-07-19HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-20Cantor FitzgeraldReiterate Overweight
2024-05-16Roth MKMReiterate Buy -> Buy
2024-03-19Alliance Global PartnersInitiate Buy
2024-03-15Roth MKMReiterate Buy
2023-11-29Roth MKMMaintains Buy -> Buy
2023-08-15Cantor FitzgeraldReiterate Overweight -> Overweight
2023-05-16Cantor FitzgeraldMaintains Overweight -> Overweight
2023-04-06BenchmarkReiterate Speculative Buy
2022-08-04Ladenburg ThalmannInitiate Buy
2022-07-14B. Riley SecuritiesMaintains Buy
2021-04-20Roth CapitalMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
FBIO revenue by date.FBIO revenue by date.
84.513M
11.58%		57.675M
-31.76%		63.262M
9.69%		111.72M
76.60%		148.21M
32.66%		680.14M
358.90%		721.75M
6.12%		736.44M
2.04%
EBITDA
YoY % growth
FBIO ebitda by date.FBIO ebitda by date.
-133.245M
32.08%		-106.776M
19.86%		-65.56M
38.60%		-34.17M
47.88%		-12.342M
63.88%		N/AN/AN/A
EBIT
YoY % growth
FBIO ebit by date.FBIO ebit by date.
-139.242M
31.60%		-111.24M
20.11%		-70.221M
36.87%		-28.18M
59.87%		-12.342M
56.20%		180.74M
1,564.43%		195.84M
8.35%		188.5M
-3.75%
Operating Margin
FBIO operating margin by date.FBIO operating margin by date.
-164.76%-192.87%-111.00%-25.22%-8.33%26.57%27.13%25.60%
EPS
YoY % growth
FBIO eps by date.FBIO eps by date.
-8.97
38.18%		-3.27
63.55%		-0.88
73.09%		0.01
101.16%		1.54
15,000.00%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FBIO Yearly Revenue VS EstimatesFBIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
FBIO Yearly EPS VS EstimatesFBIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
108.71%
Revenue Next 5 Year
57.99%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FORTRESS BIOTECH INC / FBIO Forecast FAQ

Can you provide the average price target for FORTRESS BIOTECH INC stock?

8 analysts have analysed FBIO and the average price target is 10.97 USD. This implies a price increase of 366.6% is expected in the next year compared to the current price of 2.35.

When does FORTRESS BIOTECH INC (FBIO) report earnings?

FORTRESS BIOTECH INC (FBIO) will report earnings on 2026-05-13.

What is the expected long term growth rate for FORTRESS BIOTECH INC (FBIO)?

The expected long term growth rate for FORTRESS BIOTECH INC (FBIO) is 108.71%.